Cranberries and cancer: An update of preclinical studies evaluating the cancer inhibitory potential of cranberry and cranberry derived constituents

Katherine M. Weh, Jennifer Clarke, Laura A. Kresty

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased infections to reduced cardiovascular disease and more recently cancer inhibition. A review of cranberry research targeting cancer revealed positive effects of cranberries or cranberry derived constituents against 17 different cancers utilizing a variety of in vitro techniques, whereas in vivo studies supported the inhibitory action of cranberries toward cancers of the esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Mechanisms of cranberry-linked cancer inhibition include cellular death induction via apoptosis, necrosis and autophagy; reduction of cellular proliferation; alterations in reactive oxygen species; and modification of cytokine and signal transduction pathways. Given the emerging positive preclinical effects of cranberries, future clinical directions targeting cancer or premalignancy in high risk cohorts should be considered.

Original languageEnglish (US)
Article number27
JournalAntioxidants
Volume5
Issue number3
DOIs
StatePublished - Sep 2016

Fingerprint

Vaccinium macrocarpon
Signal transduction
Reactive Oxygen Species
Health
Apoptosis
Cytokines
Neoplasms
Autophagy
Insurance Benefits
Glioblastoma
Esophageal Neoplasms
Direction compound
Stomach Neoplasms
Prostate
Signal Transduction
Lymphoma
Colon
Urinary Bladder
Necrosis
Cardiovascular Diseases

Keywords

  • Cancer
  • Cranberry
  • Proanthocyanidin
  • Quercetin
  • Ursolic acid

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Cranberries and cancer : An update of preclinical studies evaluating the cancer inhibitory potential of cranberry and cranberry derived constituents. / Weh, Katherine M.; Clarke, Jennifer; Kresty, Laura A.

In: Antioxidants, Vol. 5, No. 3, 27, 09.2016.

Research output: Contribution to journalReview article

@article{be83ffc61f3d4992a8c063a5a945825d,
title = "Cranberries and cancer: An update of preclinical studies evaluating the cancer inhibitory potential of cranberry and cranberry derived constituents",
abstract = "Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased infections to reduced cardiovascular disease and more recently cancer inhibition. A review of cranberry research targeting cancer revealed positive effects of cranberries or cranberry derived constituents against 17 different cancers utilizing a variety of in vitro techniques, whereas in vivo studies supported the inhibitory action of cranberries toward cancers of the esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Mechanisms of cranberry-linked cancer inhibition include cellular death induction via apoptosis, necrosis and autophagy; reduction of cellular proliferation; alterations in reactive oxygen species; and modification of cytokine and signal transduction pathways. Given the emerging positive preclinical effects of cranberries, future clinical directions targeting cancer or premalignancy in high risk cohorts should be considered.",
keywords = "Cancer, Cranberry, Proanthocyanidin, Quercetin, Ursolic acid",
author = "Weh, {Katherine M.} and Jennifer Clarke and Kresty, {Laura A.}",
year = "2016",
month = "9",
doi = "10.3390/antiox5030027",
language = "English (US)",
volume = "5",
journal = "Antioxidants",
issn = "2076-3921",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

TY - JOUR

T1 - Cranberries and cancer

T2 - An update of preclinical studies evaluating the cancer inhibitory potential of cranberry and cranberry derived constituents

AU - Weh, Katherine M.

AU - Clarke, Jennifer

AU - Kresty, Laura A.

PY - 2016/9

Y1 - 2016/9

N2 - Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased infections to reduced cardiovascular disease and more recently cancer inhibition. A review of cranberry research targeting cancer revealed positive effects of cranberries or cranberry derived constituents against 17 different cancers utilizing a variety of in vitro techniques, whereas in vivo studies supported the inhibitory action of cranberries toward cancers of the esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Mechanisms of cranberry-linked cancer inhibition include cellular death induction via apoptosis, necrosis and autophagy; reduction of cellular proliferation; alterations in reactive oxygen species; and modification of cytokine and signal transduction pathways. Given the emerging positive preclinical effects of cranberries, future clinical directions targeting cancer or premalignancy in high risk cohorts should be considered.

AB - Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased infections to reduced cardiovascular disease and more recently cancer inhibition. A review of cranberry research targeting cancer revealed positive effects of cranberries or cranberry derived constituents against 17 different cancers utilizing a variety of in vitro techniques, whereas in vivo studies supported the inhibitory action of cranberries toward cancers of the esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Mechanisms of cranberry-linked cancer inhibition include cellular death induction via apoptosis, necrosis and autophagy; reduction of cellular proliferation; alterations in reactive oxygen species; and modification of cytokine and signal transduction pathways. Given the emerging positive preclinical effects of cranberries, future clinical directions targeting cancer or premalignancy in high risk cohorts should be considered.

KW - Cancer

KW - Cranberry

KW - Proanthocyanidin

KW - Quercetin

KW - Ursolic acid

UR - http://www.scopus.com/inward/record.url?scp=85010380294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010380294&partnerID=8YFLogxK

U2 - 10.3390/antiox5030027

DO - 10.3390/antiox5030027

M3 - Review article

C2 - 27548236

AN - SCOPUS:85010380294

VL - 5

JO - Antioxidants

JF - Antioxidants

SN - 2076-3921

IS - 3

M1 - 27

ER -